Announced Sat, 30 May · 22:39 IST

Financial Results

Revenue Growth 20pctEbitda Margin ExpansionDebt Equity ThresholdResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-13.3%1-day move

₹151.00

prior close

₹133.90

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.8-2.9-5.5-5.2-13.3-14.2-16.6-18.1-16.6-25.8-22.3———

Up moveDown movePending

AI summary

Ravelcare Ltd reported audited standalone financial results for FY2026 with an unmodified (clean) audit opinion from Ratan Chandak & Co. LLP. The company re-appointed M/s Mahesh Dhabalia & Co. as internal auditors for FY2026-27. Total assets and equity nearly tripled from ₹1162.44 Lakh to ₹3762.62 Lakh. Share capital increased from ₹500.50 Lakh to ₹685.90 Lakh, and reserves surged significantly from ₹535.85 Lakh to ₹3054.94 Lakh. Notably, trade receivables jumped dramatically from ₹247.61 Lakh to ₹7105.61 Lakh. The company maintains zero debt (no long-term or short-term borrowings). Half-year figures are derived from audited full-year and H1 FY2026 data.

Likely market impact

The tripling of balance sheet size indicates either significant business expansion, fresh capital infusion, or revaluation of assets. Zero debt and growing reserves are positives. However, the massive jump in trade receivables relative to revenue may warrant closer monitoring of cash collection efficiency and revenue quality.